« Back to Record
Devos, T., Selleslag, D., Granacher, N., Havelange, V., & Benghiat, F. (2022). Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis. Hematology, 27(1), 23-31. doi:10.1080/16078454.2021.2009645
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/339124



